|
Index of reports
> Cases with Drug Interaction ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kaletra (Lopinavir / Ritonavir) where reactions include drug interaction. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Kaletra side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-23
Patient: 36 year old female
Reactions: Viral Load Increased, Maternal Exposure During Pregnancy, Drug Interaction
Drug(s) suspected as cause:
Nevirapine
Indication: Product Used FOR Unknown Indication
Abacavir Sulfate / Lamivudine
Indication: Product Used FOR Unknown Indication
Omeprazole
Omeprazole
Indication: Product Used FOR Unknown Indication
Reyataz
Indication: Product Used FOR Unknown Indication
Kaletra
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Folic Acid
Possible Kaletra side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-13
Patient: male, weighing 64.9 kg (142.8 pounds)
Reactions: Vomiting, Nausea, Anaemia, Rectal Haemorrhage, Drug Interaction, Cushing's Syndrome, Blood Potassium Decreased, Oedema Peripheral, Compression Fracture, Thoracic Vertebral Fracture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient possibly interacting with the suspect drug:
Triamcinolone
Indication: Compression Fracture
Start date: 2012-01-01
End date: 2012-01-01
Possible Kaletra side effects in 34 year old female
Reported by a pharmacist from Canada on 2012-03-13
Patient: 34 year old female
Reactions: Addison's Disease, Pituitary-Dependent Cushing's Syndrome, Adrenal Insufficiency, Drug Interaction, Hyperadrenalism
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient possibly interacting with the suspect drug:
Symbicort
Indication: Product Used FOR Unknown Indication
Truvada
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Methadon HCL TAB; Ranitidine; Gabapentin; Bupropion HCL; Furosemide
Possible Kaletra side effects in 34 year old female
Reported by a pharmacist from Canada on 2012-01-30
Patient: 34 year old female
Reactions: Addison's Disease, Adrenal Suppression, Drug Interaction, Cushing's Syndrome
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Tenofovir Disoprosil Fumarate (Viread); Truvada; Symbicort
Possible Kaletra side effects in female
Reported by a physician from France on 2011-12-02
Patient: female
Reactions: Foot Fracture, Drug Interaction, RIB Fracture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient possibly interacting with the suspect drug:
Cyclosporine
Indication: Eye Disorder
Start date: 2008-01-01
Cyclosporine
Indication: Sjogren's Syndrome
Truvada
Dosage: 200/245mg
Indication: HIV Infection
Start date: 2011-01-01
Possible Kaletra side effects in 57 year old female
Reported by a physician from Switzerland on 2011-10-14
Patient: 57 year old female, weighing 50.0 kg (110.0 pounds)
Reactions: Weight Decreased, Drug Interaction, Hypokalaemia, Proteinuria, Renal Tubular Acidosis, Glomerulonephropathy, Decreased Appetite, Fanconi Syndrome, Lymphopenia, Anaemia, Renal Tubular Atrophy, Haematuria, Kidney Fibrosis, Hypophosphataemia, Renal Impairment, Renal Failure, Glycosuria
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient possibly interacting with the suspect drug:
Truvada
Administration route: Oral
Indication: HIV Infection
Possible Kaletra side effects in 57 year old female
Reported by a physician from Switzerland on 2011-10-12
Patient: 57 year old female, weighing 50.0 kg (110.0 pounds)
Reactions: Weight Decreased, Fanconi Syndrome, Haematuria, Kidney Fibrosis, Lymphopenia, Renal Tubular Atrophy, Anaemia, Drug Interaction, Hypokalaemia, Hypophosphataemia, Renal Failure, Renal Impairment, Glycosuria, Proteinuria, Renal Tubular Acidosis, Glomerulonephropathy, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient possibly interacting with the suspect drug:
Truvada
Administration route: Oral
Indication: HIV Infection
Possible Kaletra side effects in male
Reported by a physician from United States on 2011-10-06
Patient: male, weighing 78.1 kg (171.8 pounds)
Reactions: Presyncope, Drug Interaction, Prostatomegaly, Urinary Retention, Loss of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alfuzosin Hydrochloride
Indication: Benign Prostatic Hyperplasia
Start date: 2009-01-01
End date: 2011-09-01
Kaletra
Indication: HIV Test Positive
Start date: 2011-01-01
Other drugs received by patient: Testim; Pristiq; Iron; Levothyroxine Sodium; Truvada; Centrum Silver; Zinc
Possible Kaletra side effects in male
Reported by a consumer/non-health professional from United States on 2011-10-05
Patient: male, weighing 78.1 kg (171.8 pounds)
Reactions: Presyncope, Prostatomegaly, Drug Interaction, Urinary Retention, Loss of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Indication: HIV Test Positive
Start date: 2011-01-01
Alfuzosin Hydrochloride
Indication: Benign Prostatic Hyperplasia
Start date: 2009-01-01
End date: 2011-09-01
Other drugs received by patient: Pristiq; Centrum Silver; Levothyroxine; Zinc; Testim; Iron; Truvada
Possible Kaletra side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2011-10-04
Patient: 61 year old female
Reactions: Dyspnoea, Hypersensitivity, Localised Oedema, Drug Interaction
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient possibly interacting with the suspect drug:
Cinacalcet
Indication: Parathyroid Disorder
Saquinavir Mesilate
Administration route: Oral
Indication: Asymptomatic HIV Infection
Kaletra
Dosage: 533.2/133.3mg
Administration route: Oral
Cinacalcet
Dosage: 1 tablet at night for 3 nights
Administration route: Oral
Indication: Hyperparathyroidism
Start date: 2009-01-01
End date: 2009-01-01
Other drugs received by patient: Calcitriol; Moxifloxacin; Lamivudine (Epivir Hbv); Venofer; Erythropoietin Human
|
